Future directions for clinical psilocybin research: The relaxed symptom network.

What is it about?

Psilocybin-assisted psychotherapy (PAP) has seen an explosion of interest in the past decade, with preliminary clinical data looking particularly promising for the treatment of depressive disorders. In this article, we highlight that future clinical research conducted with psilocybin would benefit from the application of the network theory, a novel method to classify and diagnose mental health disorders. We argue that the application of the network theory would ultimately improve responsiveness to PAP and reduce the rate of relapse in response to this promising therapeutic modality.

Featured Image

Photo by FLY:D on Unsplash

Photo by FLY:D on Unsplash